Adoption of Multiple Strategies to Reduce the Rate of Marker Detachment During Radiotherapy in Patients With Cancer

Radiation Therapy Clinical Trial

Official title:

Adoption of Multiple Strategies to Reduce the Rate of Marker Detachment During Radiotherapy in Patients With Cancer

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT06132295
• Other study ID #: 2023-A-037
• Status: Completed
• Phase: N/A
• Start date: January 1, 2023
• Est. completion date: June 30, 2023

Study information

• Verified date: July 2023
• Source: Chung Shan Medical University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Investigators used in-house-designed radiotherapy red and green light markers to distinguish individual measures after the provision of the initial nursing care to participants, added a homemade health education leaflet to collect data via actual observation, and counted the disappearance or fading of participants' body markers

Description:

From January 1, 2023 to June 30, 2023, a total of 200 participants were enrolled and undergoing radiation therapy. Inclusion Criteria: clear consciousness who could understand and comprehend Mandarin Chinese. Exclusion Criteria: patients with impaired consciousness or decreased cognitive abilities. Investigators proposed a set of strategic initiatives : 1. Consistent Schedule for the Replacement of Positioning Line Pens: Consistent Schedule for the Replacement of Positioning Line Pens: Investigators recommend implementing a standardized replacement schedule for positioning line pens, with replacement performed after every 50 uses. 2. Tailored Educational Content: Investigators created personalized educational content tailored to each patient's educational background. This approach ensures that participants can easily understand their treatment plan. 3. Hypoallergenic Adhesive Patches: Investigators offered a variety of hypoallergenic adhesive patches, catering to the skin characteristics of individual participants. 4. Enriched Treatment Care Platform: Investigators commitment extended to creating a comprehensive treatment care platform, which provided guidance on positioning line usage, interactive community features, and practical information. 5. Participants with BMI > 25 and an education level of high school or below, without specific caregivers, were identified by placing a red dot on the treatment record and on the patient's happiness card. Patients with BMI < 25 and an education level of high school or above, with specific caregivers, were identified by placing a green dot on their records. 6. After implementing the red-green light differentiation for radiation therapy and individual interventions, educational pamphlets prepared in-house were added, to assess the maintenance status of the positioning marks. The number of times the surface marks disappeared or faded during treatment was recorded on the day the participants completed treatment.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 200
• Est. completion date: June 30, 2023
• Est. primary completion date: June 30, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• participants with clear consciousness.
• participants could understand and comprehend Mandarin Chinese.

Exclusion Criteria:

• participants with impaired consciousness or decreased cognitive abilities.

Related Conditions & MeSH terms

• Cancer Patients
• Radiation Therapy
• Tattooing

Intervention

Other:
• Nursing care
Consistent Schedule for the Replacement of Positioning Line Pens Tailored Educational Content Hypoallergenic Adhesive Patches Enriched Treatment Care Platform Participants with BMI > 25 and an education level of high school or below, without specific caregivers, were identified by placing a red dot on the treatment record and on the patient's happiness card. Patients with BMI < 25 and an education level of high school or above, with specific caregivers, were identified by placing a green dot on their records. Individual interventions, educational pamphlets prepared in-house were added, to assess the maintenance status of the positioning marks.

Locations

Country	Name	City	State
Taiwan	Chung Shan Medical University	Taichung City	Taiwan (r.o.c.)

Sponsors (1)

Lead Sponsor	Collaborator
Chung Shan Medical University

Country where clinical trial is conducted

Taiwan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The number of times the surface marks disappeared or faded	The number of times the surface marks disappeared or faded during treatment was recorded on the day the participants immediately after the radiotherapy.	The day the participants immediately after the radiotherapy.